Skip to main content
Mike Eckrote

Mike Eckrote

Mike Eckrote is Senior Vice President of Strategic Solutions & CRO Channel at Advarra, focused on clinical trial technology and AI-driven innovation.

Oct 27, 2026

7:35
And Mike, I'd love to sort of hear your thoughts on it because I know you're approaching it in a slightly more technical way.
7:41
I think the points that Travis raised in terms of using it for productivity and thinking of it as a doer of tasks is probably the simplest, most rudimentary way to break it down into the most fundamental pieces, which is that in any area where you could have a human going and delegating tasks, effectively a task list with instructions, we can assign agents to then go run a battery of tasks on our behalf, right? And that is an oversimplification.
8:08
But when you think about artificial intelligence and our ability to drive automation, fundamentally, that is the way I think you can think about an agent.
8:14
When we think about agent to agent interaction, there's probably two ways I would decompose it, right? The first being, if you think about in a particular system, one agent can also communicate with other agents to orchestrate tasks.
8:26
So if to then go run a battery of tasks, but maybe there's one task in that list that they're not an expert at.
8:36
Somebody who is building these systems can start further upstream and effectively build the strategy to say, okay, to facilitate this task, you're going to have to go talk over here, right? So that's the way I think we can allow agents to speak across a outside of the boundaries of the organization.
9:04
So as an example, in clinical research, we work in a very data-heavy industry.
11:27
How can these agents help all of those systems coordinate intelligence and work across organizational boundaries rather than requiring everyone to operate within the exact same platform?
0:20
Mike, thanks for being here, and I'd like for you to start by talking about the technology that Advarra is deploying and the problems that it's aiming to solve.
0:29
I think at the, starting at the highest level, our product and technology leadership here at Advarra have used the, the model around build once, deploy everywhere, right? Which is if we can build a really strong foundation, which is what we call Parade, which is in simplest terms, it's a data backbone governance structure, AI strategy that will allow us to put AI in many different parts of our business and where we sit in the ecosystem as Advarra.
1:00
Now, again, not only the largest central IRB, but also the largest provider of site technologies.
1:04
We see from a data perspective, obviously there's a lot of different artifacts and data fragments in our orbit, and I think if you think about the protocols themselves as an example, there are tons of lessons to be learned and derivative insights to be gained from those trials, not only on day one when they show up via the central IRB, but the, the different permutations of, of the trial, the different evolution of those protocols and those studies over time, which often go unnoticed, right? So if you think about your coupling the baseline design with what was the actual outcome that happened in the real world, whether it be the evolution of the protocol, as I mentioned, but also what happened at the site level, right? So via the, again, the view of the world we have by being the leading site technology o- offering, we see actually how poorly designed trials impact research sites too, as well, directly.
1:58
So I think it is the, the sort of dual thread of being able to see what happens on day one, the evolution of those things over time via why trials get amended, right, the, the rationale behind those amendments, how those amendments potentially impact patient burden, how they impact site burden, how they impact recruitment velocity, and then ultimately outcomes at the sites.
2:22
That, that's where we see sort of a complete picture or, or a complete view of the world.

16 MINS LATER

18:18
What would be your advice for sponsors about how to evaluate when to use AI, what to look for in AI partners to make sure that it's actually useful for them?
18:32
The reality is nobody has been doing these cutting-edge techniques and approaches for 20 years, right? So if you want to go to an organization that's gonna be doing something on the bleeding edge, but they have 10 years of case studies and anecdotes, we're just not at that state of affairs yet.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.